Assoc. Prof. Dr. Anjar Tri Wibowo
Department of Biology, Faculty of Science and Technology, Universitas Airlangga
Department of Biology, Faculty of Science and Technology, Universitas Airlangga Speaker Profile : Introducing Dr. Anjar Tri Wibowo: a distinguished academic with extensive expertise in Plant Microbiome, Metabolomics, Epigenetics, and Genomics. His research group has focused on examining the intricate relationships between plants and their microbial communities, significantly enhancing our understanding in this area. As a keynote speaker at our conference on the metabolomics and microbiome of Indonesian medicinal plants, Dr. Wibowo offers valuable insights drawn from his extensive research. His work sheds light on the chemical composition, genetic characteristics, and microbes associated with of Indonesia's medicinal flora, contributing to the field of cultivation and utilization of herbal medicine. Dr. Wibowo's presentation will explore the relationship between metabolomics and microbiomes in Indonesia medicinal plants, highlighting the various types of microorganisms that can affect the production of secondary metabolites, growth rate, and tolerance levels to various environmental stresses in plants. The long-term goal of this research is to develop microbiome engineering technologies (e.g., biofertilizer applications) to improve the quality of Indonesia's medicinal plants. His methodical and insightful approach is expected to provide the audience with a deeper understanding and foster meaningful discussions.

Prof. Dr. Teh Lay Kek
Professor & Deputy Director, Integrative Pharmacogenomics Institute, Universiti Teknologi MARA, Malaysia
Being one of the few PhD graduates in pharmacogenetics in early 2000, Prof.Teh had conducted research to understand the impact of pharmacogenetics and developed simple PCR based methods for detection of genetic variants. A few genotyping tests are currently in use to help the doctor (i) to identify patients at risk of severe adverse effect such as carbamazepine induced Steven Johnson syndrome and Toxic Epidermal Necrolysis (HLA-B*15:02 genotyping kit), warfarin induced fatal bleeding and aspirin induced gastritis; (ii) to identify patients resistant to clopidogrel, warfarin, primaquine, antipsychotic drugs, tamoxifen. Together with the research team, they had also developed sport genomics, nutrigenetics and food allergies genetic tests to enhance sport and food industries in moving forward with more precise strategies. These genetic tests had won innovation awards at national and international levels and some of the primers and detection protocol had received patents and copyrights. Prof. Teh and the research team is the first group in Malaysia that had successfully sequenced and reported on the whole genome sequences of an individual Malay in 2013. They subsequently developed whole genome sequencing pipeline and genotype-phenotype database, which are currently used for precision health. They had established a start-up company registered as Zakesy Biotech S/B to commercial Personal Genome Analysis and pharmacogenotyping tests. She has won several grants and were the principal Investigator for a total grants and contract research amounting to RM 1.9 million. In addition, she has 3 patents and 1 trademark registered. She is also the President for Malaysian Metabolomics Society and Co-Chair for Pharmacogenomics Global Research Network, Developing Countries (Asian Countries).